China Hemp, Cannabis and CBD Importing and Exporting Regulatory Report 2021 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 16, 2021--
The “Regulatory Report: China - Importing and Exporting Hemp, Cannabis and CBD” report has been added to ResearchAndMarkets.com’s offering.
Unlike import, export of CBD products is not strictly controlled in China and mainly depends on the rules of the destination country. This report takes a closer look at import and export regulation in China, covering hemp, CBD and cannabis, including full/broad-spectrum extracts, CBD isolate and finished products (food, cosmetics and vaping).
Cannabis, cannabis resin, extracts and tinctures are listed in the Chinese catalogue of narcotic drugs and psychotropic drugs, meaning they cannot be imported for commercial purposes or purchased from overseas by consumers.
While the Customs Order No.43 explicitly prohibits cannabis entry to China, these substances could still qualify for a narcotic and psychotropic drugs import and export permit. According to the application guidance, the import licence can only be approved for medical and scientific purposes.
Find out more about import and export in this report.
Key Topics Covered:
1 Executive summary
4 CBD isolate
5 Full/broad-spectrum extracts
6 Finished products
7 Relevant laws
8 Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/bwsgo5
View source version on businesswire.com:https://www.businesswire.com/news/home/20210716005331/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: CHINA ASIA PACIFIC
INDUSTRY KEYWORD: TOBACCO RETAIL ALTERNATIVE MEDICINE HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 07/16/2021 10:14 AM/DISC: 07/16/2021 10:14 AM